| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/12/2014 | WO2014135572A1 Tablet formulation of a pi3kalpha inhibitor |
| 09/12/2014 | WO2014135524A1 Cabazitaxel and its use for treating metastatic prostate cancers |
| 09/12/2014 | WO2014135480A1 Substituted thiazolopyrimidines |
| 09/12/2014 | WO2014135460A1 Use of (rs)-s-cyclopropyl-s-(4-{[4-{[(1r,2r)-2-hydroxy-1-methylpropyl]- oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide for treatment of specific tumours |
| 09/12/2014 | WO2014135245A1 9-(aryl or heteroaryl)-2-(pyrazolyl, pyrrolidinyl or cyclopentyl)aminopurine derivatives as anticancer agents |
| 09/12/2014 | WO2014135244A1 Triazolo[4,5-d]pyrimidine derivatives for the treatment of diseases such as cancer |
| 09/12/2014 | WO2014135043A1 Crystal form of ixabepilone and the preparation method and use thereof |
| 09/12/2014 | WO2014135028A1 Pyridopyrimidine or pyrimidopyrimidine compound, preparation method, pharmaceutical composition and use thereof |
| 09/12/2014 | WO2014134968A1 Pyrrolidonopyrazole compounds and use thereof as drugs |
| 09/12/2014 | WO2014134840A1 Treatment of cervical cancer and/or ovarian cancer using transcription factor modulator |
| 09/12/2014 | WO2014134800A1 Treatment of cervical cancer and/or ovarian cancer using transcription factor modulator |
| 09/12/2014 | WO2014134750A1 2,6,9-trisubstituted purine derivative and preparation method and use thereof |
| 09/12/2014 | WO2014134705A1 Quinoline sulfonyl derivatives and uses thereof |
| 09/11/2014 | US20140256743 Cathepsin cysteine protease inhibitors |
| 09/11/2014 | US20140256652 Polypeptides Involved In Immune Response |
| 09/11/2014 | US20140255410 Specific binding proteins and uses thereof |
| 09/11/2014 | DE102013004454A1 Mittel zur Sensibilisierung solider, maligner Tumore gegenüber Chemotherapeutika und Strahlentherapie Means of raising awareness of solid, malignant tumors to chemotherapy and radiotherapy |
| 09/11/2014 | DE102013003107A1 Naphthofurandione mit einer 1-Bromalkylgruppe oder einer 1-Hydroxyalkylgruppe in 2-Position und einer Alkylgruppe in 3-Position zum Furanring-Sauerstoff und Verfahren zu deren Herstellung Naphthofurandione with a 1-bromoalkyl group or a 1-hydroxyalkyl group at the 2-position and an alkyl group in the 3-position on the furan ring-oxygen and methods for their preparation |
| 09/10/2014 | EP2775001A1 MicroRNA signatures in human ovarian cancer |
| 09/10/2014 | EP2774984A1 Monoclonal antibody against human non-small-cell lung carcinoma and use thereof |
| 09/10/2014 | EP2774912A1 Cationic lipid |
| 09/10/2014 | EP2774910A1 Enantiomers of 2-hydroxy derivatives of fatty acids |
| 09/10/2014 | EP2774611A1 Magnetic composition, and method for producing same |
| 09/10/2014 | EP2773960A1 Diagnostic and treatment of an androgen-independent prostate cancer |
| 09/10/2014 | EP2773673A1 Fusion protein comprising c-terminal domain of ret protein and use thereof as a diagnosing marker |
| 09/10/2014 | EP2773671A1 Stable heterodimeric antibody design with mutations in the fc domain |
| 09/10/2014 | EP2773645A1 Imidazopyridazine compounds |
| 09/10/2014 | EP2773642A1 Pak inhibitors for the treatment of cell proliferative disorders |
| 09/10/2014 | EP2773640A1 Bicyclic piperazine compounds |
| 09/10/2014 | EP2773639A1 Alkylated piperazine compounds as inhibitors of btk activity |
| 09/10/2014 | EP2773638A1 Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity |
| 09/10/2014 | EP2773632A1 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity |
| 09/10/2014 | EP2773623A1 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof |
| 09/10/2014 | EP2773619A1 New aryl-quinoline derivatives |
| 09/10/2014 | EP2773427A2 Medical use |
| 09/10/2014 | EP2773426A1 Combinational liposome compositions for cancer therapy |
| 09/10/2014 | EP2773373A1 Methods of blocking cancer stem cell growth |
| 09/10/2014 | EP2773360A2 Administration of nedd8-activating enzyme inhibitor and hypomethylating agent |
| 09/10/2014 | EP2773353A1 N-(3-{[(3-{[2-chloro-5-(methoxy)phenyl]amino}quinoxalin-2-yl)amino]sulfonyl}phenyl)-2-methylalaninamide as phosphatidylinositol 3-kinase inhibitor for the treatment of lymphoproliferative malignancies |
| 09/10/2014 | EP2773346A1 Pharmaceutical compositions of hydrophobic camptothecin derivatives |
| 09/10/2014 | EP2773345A1 Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors |
| 09/10/2014 | EP2773340A1 Use of neu1 sialidase inhibitors in the treatment of cancer |
| 09/10/2014 | EP2773322A1 Methods for treating cancers using oral formulations of cytidine analogs |
| 09/09/2014 | US8829185 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 09/09/2014 | US8829021 Treatment of pediatric tumors |
| 09/09/2014 | US8829013 Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
| 09/09/2014 | US8828959 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 09/09/2014 | US8828947 Polypeptide formulation |
| 09/09/2014 | US8828944 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject |
| 09/09/2014 | US8828934 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/09/2014 | US8828391 Method for EGFR directed combination treatment of non-small cell lung cancer |
| 09/09/2014 | US8828385 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 09/09/2014 | US8828381 Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas |
| 09/09/2014 | US8828375 Expansion of haemopoietic precursors |
| 09/09/2014 | CA2802130C Cyanoquinoline derivatives |
| 09/09/2014 | CA2674908C Tri-demethylation-capable protein complex, method of its preparation and its use |
| 09/09/2014 | CA2660324C Plasmids with immunological action |
| 09/09/2014 | CA2655750C 2-arylindole derivatives as mpges-1 inhibitors |
| 09/09/2014 | CA2652840C 2-piperazino-6-chloro-pteridines as pde4-inhibitors for the treatment of inflammatory diseases |
| 09/09/2014 | CA2645350C Novel bis-2-difluoro-pyrrolo[2,1-c][1,4]benzodiazepine dimmers |
| 09/09/2014 | CA2598879C Prostate stem cell |
| 09/09/2014 | CA2473733C Cytokine receptor zcytor17 multimers |
| 09/09/2014 | CA2436242C Biotin-derivatives and their conjugates with chelating agents |
| 09/04/2014 | WO2014134426A1 USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3Kδ RELATED DISORDERS |
| 09/04/2014 | WO2014134355A1 Drug combinations |
| 09/04/2014 | WO2014134308A1 Substituted 7-oxo-pyrido [2, 3-d] pyrimidines and their use for the treatment of egfr / erbb2 related disorders |
| 09/04/2014 | WO2014134267A1 Carbazole compounds useful as bromodomain inhibitors |
| 09/04/2014 | WO2014134240A1 Treatment of cancer with tor kinase inhibitors |
| 09/04/2014 | WO2014134232A1 Carbazole compounds useful as bromodomain inhibitors |
| 09/04/2014 | WO2014134201A1 A benzoic acid derivative mdm2 inhibitor for the treatment of cancer |
| 09/04/2014 | WO2014134169A1 Inhibitors of cdk8/19 for use in treating estrogen receptor positive breast cancer |
| 09/04/2014 | WO2014134038A1 Compositions and methods relating to induction of intestinal stem cell homeogenesis and/or regeneration |
| 09/04/2014 | WO2014133950A1 Particle compositions and methods related thereto |
| 09/04/2014 | WO2014133316A1 Antibodies against tm4sf5 and anticancer compositions comprising the same |
| 09/04/2014 | WO2014133204A1 Heat releasing composition comprising shape anisotropic nanomaterial |
| 09/04/2014 | WO2014132235A1 Method for the production of sub-micrometric particles and their theranostic use in oncology with a specific apparatus |
| 09/04/2014 | WO2014131777A1 Inhibitors of histone demethylases |
| 09/04/2014 | WO2014131715A1 Anti-mcsp antibodies |
| 09/04/2014 | WO2014131712A1 Bispecific t cell activating antigen binding molecules |
| 09/04/2014 | WO2014131694A1 Bispecific t cell activating antigen binding molecules |
| 09/04/2014 | WO2014108571A3 Cancer drug and uses |
| 09/04/2014 | WO2014108484A3 Combination therapy of anti-her3 and anti-her2 antibodies |
| 09/04/2014 | WO2014106459A3 Method for treating tumor by using recombinant interferon with changed spatial configuration |
| 09/04/2014 | WO2014068597A3 Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof |
| 09/04/2014 | WO2013123588A9 Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer |
| 09/04/2014 | WO2009134574A3 Disubstituted phthalazine hedgehog pathway antagonists |
| 09/04/2014 | US20140248700 Method of Differentiation of Morula or Inner Cell Mass Cells and Method of Making Lineage-Defective Embryonic Stem Cells |
| 09/04/2014 | US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 09/04/2014 | US20140248609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 09/04/2014 | DE10297513C5 In vitro Herstellung von dendritischen Zellen aus CD14+ Monocyten In vitro production of dendritic cells from CD14 + monocytes |
| 09/03/2014 | EP2772498A1 Polypeptides inhibiting neovascularization and uses thereof |
| 09/03/2014 | EP2772491A1 Crystals of androgen receptor antagonist compound |
| 09/03/2014 | EP2772486A1 Kinase inhibitor and method for treatment of related diseases |
| 09/03/2014 | EP2772464A2 Type zinc- phthalocyanine nanowires having enhanced water solubility and water dispersibility, composite of an -type zinc- phthalocyanine nanowire/phenothiazine, and method for preparing same |
| 09/03/2014 | EP2772260A2 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment |
| 09/03/2014 | EP2772257A1 Formulations of quinolinones |
| 09/03/2014 | EP2771688A1 Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer |
| 09/03/2014 | EP2771685A1 Biomarkers of cancer |
| 09/03/2014 | EP2771464A2 Methods of treating cancer |
| 09/03/2014 | EP2771363A1 Cd44 monoclonal antibody for the treatment of b-cell chronic lymphocytic leukemia and other hematological malignancies |